⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Tech Data (TECD) Earnings, Sales Surpass Estimates In Q3

Published 11/30/2018, 03:12 AM
Updated 07/09/2023, 06:31 AM
PLCE
-
TECD_old
-
BOOT
-
GOOS
-

Tech Data Corporation (NASDAQ:TECD) posted robust third-quarter fiscal 2019 results, wherein both the top and bottom lines surpassed the Zacks Consensus Estimate. Results were backed by double-digit growth in all the three regions coupled with improvement in operating margins.

The company reported adjusted earnings of $3.02 per share in the third quarter of fiscal 2019. The figure not only surpassed the Zacks Consensus Estimate of $2.19 but also increased 51% on a year-over-year basis. Moreover, net sales of $9,340 million increased 11% year over year and surpassed the consensus mark of $8,875 million. Net sales rose 12% on a constant-currency (cc) basis.

Net sales from the Americas (44.3% of revenues) rose 12.9% to $4.1 billion. Sales from Europe (52.7% of revenues) grew 8.9% to $4.9 billion and from Asia-Pacific (3% of revenues) increased 5.9% to $282 million.

Tech Data Corporation Price, Consensus and EPS Surprise

Margins

Gross margin contracted 27 basis points (bps) from the year-ago quarter to 6%. Non-GAAP selling, general & administrative (SG&A) expenses as a percentage of revenues decreased 67 bps to 3.95% in the reported quarter.

Adjusted operating margin expanded 40 bps to 2%. Segment wise, operating margin expanded 68 bps for the Americas, 16 bps for Europe and 6 bps for Asia-Pacific.

Balance Sheet and Cash Flow

As of Sep 30, 2018, Tech Data had cash and cash equivalents of approximately $646.5 million, long-term debt of $1.3 billion and total stockholders’ equity of $2.8 billion.

During the quarter, the company bought back about 621,000 shares for $44 million. Tech Data generated cash from operations of $155 million in the reported quarter.

Outlook

Tech Data issued fourth-quarter fiscal 2019 view. It expects adjusted earnings of $3.90-$4.20 per share with tax rate of 24-26%.

Price Performance

We note that shares of this Zacks Rank #1 (Strong Buy) company have gained 28.4% in the past month, outperforming the industry’s growth of 3.8%.



Looking for More? Check These Solid Picks

Boot Barn Holdings (NYSE:BOOT) , with long-term earnings per share growth rate of 23%, sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Canada Goose Holdings (NYSE:GOOS) , with long-term earnings per share growth rate of 31.3%, carries a Zacks Rank #2 (Buy).

Children’s Place, Inc. (NASDAQ:PLCE) , with long-term earnings per share growth rate of 8%, carries a Zacks Rank #2.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>



Children's Place, Inc. (The) (PLCE): Free Stock Analysis Report

Canada Goose Holdings Inc. (GOOS): Free Stock Analysis Report

Tech Data Corporation (TECD): Free Stock Analysis Report

Boot Barn Holdings, Inc. (BOOT): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.